Header Logo

Connection

PAUL HOPKINS to Coronary Disease

Back to Details
This is a "connection" page, showing publications PAUL HOPKINS has written about Coronary Disease.
PAUL HOPKINS
Connection Strength
1.690
Coronary Disease
  1. Chocolate consumption is inversely associated with prevalent coronary heart disease: the National Heart, Lung, and Blood Institute Family Heart Study. Clin Nutr. 2011 Apr; 30(2):182-7.
    View in: PubMed
    Score: 0.254
  2. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Curr Atheroscler Rep. 2007 Sep; 9(3):179-86.
    View in: PubMed
    Score: 0.206
  3. Association of coronary artery calcified plaque with clinical coronary heart disease in the National Heart, Lung, and Blood Institute's Family Heart Study. Am J Cardiol. 2006 Jun 01; 97(11):1564-9.
    View in: PubMed
    Score: 0.187
  4. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2001 Mar 01; 87(5):547-53.
    View in: PubMed
    Score: 0.131
  5. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study. Atherosclerosis. 1998 Dec; 141(2):333-45.
    View in: PubMed
    Score: 0.112
  6. Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1997 Nov; 17(11):2783-92.
    View in: PubMed
    Score: 0.104
  7. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996 Feb; 16(2):250-5.
    View in: PubMed
    Score: 0.092
  8. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1995 Sep; 15(9):1314-20.
    View in: PubMed
    Score: 0.090
  9. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994 Apr; 40(4):552-61.
    View in: PubMed
    Score: 0.081
  10. Human genetics and coronary heart disease: a public health perspective. Annu Rev Nutr. 1989; 9:303-45.
    View in: PubMed
    Score: 0.056
  11. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988 Oct 01; 62(10 Pt 1):703-7.
    View in: PubMed
    Score: 0.055
  12. Evidence of QTL on 15q21 for high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study (NHLBI FHS). Atherosclerosis. 2007 Jan; 190(1):232-7.
    View in: PubMed
    Score: 0.046
  13. Dietary linolenic acid and adjusted QT and JT intervals in the National Heart, Lung, and Blood Institute Family Heart study. J Am Coll Cardiol. 2005 May 17; 45(10):1716-22.
    View in: PubMed
    Score: 0.044
  14. Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens. 2004 Jun; 17(6):511-5.
    View in: PubMed
    Score: 0.041
  15. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis. 2001 Feb 15; 154(3):747-54.
    View in: PubMed
    Score: 0.033
  16. Identification of a common variant in the lipoprotein lipase gene in a large Utah kindred ascertained for coronary heart disease: the -93G/D9N variant predisposes to low HDL-C/high triglycerides. Clin Genet. 2001 Feb; 59(2):88-98.
    View in: PubMed
    Score: 0.033
  17. Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. J Lipid Res. 1997 Jul; 38(7):1361-73.
    View in: PubMed
    Score: 0.025
  18. Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease. Clin Exp Pharmacol Physiol Suppl. 1992; 20:1-6.
    View in: PubMed
    Score: 0.017
  19. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S1-8.
    View in: PubMed
    Score: 0.017
  20. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med. 1990 Mar; 150(3):582-8.
    View in: PubMed
    Score: 0.015
  21. Concordant dyslipidemia, hypertension and early coronary disease in Utah families. Klin Wochenschr. 1990; 68 Suppl 20:53-9.
    View in: PubMed
    Score: 0.015
  22. Clinical application of deoxyribonucleic acid markers in a Utah family with hypercholesterolemia. Am J Cardiol. 1989 Jan 01; 63(1):109-12.
    View in: PubMed
    Score: 0.014
  23. A genome scan for loci influencing anti-atherogenic serum bilirubin levels. Eur J Hum Genet. 2002 Sep; 10(9):539-46.
    View in: PubMed
    Score: 0.009
  24. Evidence for a major gene elevating serum bilirubin concentration in Utah pedigrees. Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8):912-7.
    View in: PubMed
    Score: 0.006
  25. Familial dyslipidaemic hypertension and other multiple metabolic syndromes. Ann Med. 1992 Dec; 24(6):469-75.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.